Phase II Study Evaluating the Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem and Progenitor Cells for Allogeneic Hematopoietic Cell Transplantation and Phenotypic Characterization of the Leukapheresis Product

Rettig Michael P.; Uy Geoffrey L.; Bashey Asad; Devine Steven; Jaglowski Samantha; Vainstein Abi; Sorani Ella; Chen Hemda; Bohana-Kashtan Osnat; Shaw Stephen; Westervelt Peter; DiPersio John F.

首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Phase II Study Evaluating the Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem and Progenitor Cells for Allogeneic Hematopoietic Cell Transplantation and Phenotypic Characterization of the Leukapheresis Product

【24h】

Phase II Study Evaluating the Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem and Progenitor Cells for Allogeneic Hematopoietic Cell Transplantation and Phenotypic Characterization of the Leukapheresis Product

机译：II期研究评估BL-8040为动员供体造血干和祖细胞进行同种异体造血细胞移植的安全性和功效，以及表型施产物的表型表征

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Blood: The Journal of the American Society of Hematology》 |2018年第novaelatreatmentappr期|共3页
作者
Rettig Michael P.; Uy Geoffrey L.; Bashey Asad; Devine Steven; Jaglowski Samantha; Vainstein Abi; Sorani Ella; Chen Hemda; Bohana-Kashtan Osnat; Shaw Stephen; Westervelt Peter; DiPersio John F.;
展开▼
作者单位

Washington Univ Sch Med St Louis MO USA;

Washington Univ Sch Med St Louis MO USA;

Northside Hosp Blood &

Marrow Transplant Program Atlanta GA USA;

Ohio State Univ Minneapolis MN USA;

Ohio State Univ Hematol Columbus OH 43210 USA;

BioLineRx Ltd Modiin Israel;

BioLineRx Ltd Modiin Israel;

BioLineRx Ltd Modiin Israel;

BioLineRx Ltd Modiin Israel;

BioLineRx Ltd Modiin Israel;

Washington Univ Sch Med St Louis MO USA;

Washington Univ Sch Med St Louis MO USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Phase II Study Evaluating the Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem and Progenitor Cells for Allogeneic Hematopoietic Cell Transplantation and Phenotypic Characterization of the Leukapheresis Product [J] . Rettig Michael P., Uy Geoffrey L., Bashey Asad, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：II期研究评估BL-8040为动员供体造血干和祖细胞进行同种异体造血细胞移植的安全性和功效，以及表型施产物的表型表征
2. A Phase II study on the safety and efficacy of a single dose of pegfilgrastim for mobilization and transplantation of autologous hematopoietic stem cells in pediatric oncohematology patients. [J] . Cesaro S, Zanazzo AG, Frenos S, Transfusion: The Journal of the American Association of Blood Banks . 2011,第11期

机译：II期研究单剂量的pegfilgrastim在小儿肿瘤血液学患者中动员和移植自体造血干细胞的安全性和有效性。
3. Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation [J] . Martino Introna, Federico Lussana, Alessandra Algarotti, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2017,第12期

机译：同种异体造血干细胞移植后患者中淋巴细胞输注和细胞因子诱导杀伤细胞顺序输注的II期研究
4. EX VIVO Expansion of CD34~+ Cells in Stemline II Hematopoietic Stem Cell Expansion Medium Generates a Large Population of Functional Early and Late Progenitor Cells [C] . Stacy L. Leugers, Daniel W. Allison, Ying Liang, General Meeting of European Society of Animal Cell Technology . 2007

机译：茎线II造血干细胞膨胀介质中CD34〜+细胞的exvivo扩增产生了大量的功能性早期和晚期祖细胞
5. Donor selection for patients undergoing allogeneic hematopoietic stem cell transplantation: Assessment of the priorities of Canadian hematopoietic stem cell transplant physicians. [D] . Tay, Jason. 2009

机译：接受同种异体造血干细胞移植的患者的供体选择：加拿大造血干细胞移植医生的优先事项评估。
6. P05.02 A phase I/IIa dose escalation study evaluating the safety and efficacy of autologous CD34+ enriched hematopoietic progenitor cells genetically modified for human interferon-α2 in patients with GBM and an unmethylated MGMT promoter (TEM-GBM-001) [O] . B Gentner, F Ciceri, F DiMeco, 2019

机译：P05.02 A相I / IIA剂量升级研究评估自体CD34 +富集的造血祖细胞的安全性和功效GBM患者遗传修饰的人类干扰素-α2和未甲基化的MGMT启动子（TEM-GBM-001）
7. A pilot study evaluating the safety and efficacy of AMD3100 for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells in patients with advanced hematological malignancies [O] . Devine S.M., Todt L., Bonde J., 2006

机译：一项初步研究评估AMD3100在晚期血液系统恶性肿瘤患者中动员和移植HLA匹配的同胞供体造血干细胞的安全性和有效性

Phase II Study Evaluating the Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem and Progenitor Cells for Allogeneic Hematopoietic Cell Transplantation and Phenotypic Characterization of the Leukapheresis Product

著录项

相似文献

相关主题

期刊订阅